Patents by Inventor Arne Wang Aabye

Arne Wang Aabye has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230414792
    Abstract: The present invention provides a method for the commercial presentation of a solution of gadolinium-DOTA that provides certain advantages over the known methods.
    Type: Application
    Filed: May 18, 2023
    Publication date: December 28, 2023
    Inventors: Karina Martha LANGSETH-MANRIQUE, Arne Wang Aabye, Harald Laugen, Eva Krog Tamnes, Borge Mathisen
  • Patent number: 11730832
    Abstract: The present invention provides a method for the commercial presentation of a solution of gadolinium-DOTA that provides certain advantages over the known methods.
    Type: Grant
    Filed: October 26, 2020
    Date of Patent: August 22, 2023
    Assignee: GE HEALTHCARE AS
    Inventors: Karina Martha Langseth-Manrique, Arne Wang Aabye, Harald Laugen, Eva Krog Tamnes, Borge Mathisen
  • Publication number: 20210069355
    Abstract: The present invention provides a method for the commercial presentation of a solution of gadolinium-DOTA that provides certain advantages over the known methods.
    Type: Application
    Filed: October 26, 2020
    Publication date: March 11, 2021
    Inventors: Karina Martha LANGSETH-MANRIQUE, Arne Wang Aabye, Harald Laugen, Eva Krog Tamnes, Borge Mathisen
  • Patent number: 10941124
    Abstract: The present invention provides methods for the preparation of compounds useful in in vivo therapeutic and diagnostic applications. In particular, the present invention provides a method for the synthesis of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) and also methods for the preparation of metal chelates of DOTA.
    Type: Grant
    Filed: December 19, 2016
    Date of Patent: March 9, 2021
    Assignee: GE HEALTHCARE AS
    Inventors: Andreas Richard Meijer, Arne Wang Aabye, Khalid Hussain, Sondre Nilsen, Mikkel Jacob Thaning, Jarle Andre Haugan, Ingvil Gausemel, Nikolai Enes, Silalahi Sumihar
  • Patent number: 10842888
    Abstract: The present invention provides a method for the commercial presentation of a solution of gadolinium-DOTA that provides certain advantages over the known methods.
    Type: Grant
    Filed: January 22, 2018
    Date of Patent: November 24, 2020
    Assignee: GE Healthcare AS
    Inventors: Karina Martha Langseth-Manrique, Arne Wang Aabye, Harald Laugen, Eva Krog Tamnes, Borge Mathisen
  • Publication number: 20180370925
    Abstract: The present invention provides methods for the preparation of compounds useful in in vivo therapeutic and diagnostic applications. In particular, the present invention provides a method for the synthesis of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) and also methods for the preparation of metal chelates of DOTA.
    Type: Application
    Filed: December 19, 2016
    Publication date: December 27, 2018
    Applicant: GE Healthcare AS
    Inventors: Andreas Richard Meijer, Arne Wang Aabye, Khalid Hussain, Sondre Nilsen, Mikkel Jacob Thaning, Jarle Andre Haugan, Ingvil Gausemel, Nikolai Enes, Silalahi Sumihar
  • Publication number: 20180207297
    Abstract: The present invention provides a method for the commercial presentation of a solution of gadolinium-DOTA that provides certain advantages over the known methods.
    Type: Application
    Filed: January 22, 2018
    Publication date: July 26, 2018
    Applicant: GE HEALTHCARE AS
    Inventors: Karina Martha Langseth-Manrique, Arne Wang Aabye, Harald Laugen, Eva Krog Tamnes, Borge Mathisen